InvestorsHub Logo
Followers 121
Posts 17456
Boards Moderated 0
Alias Born 01/06/2014

Re: None

Thursday, 06/30/2016 4:12:04 PM

Thursday, June 30, 2016 4:12:04 PM

Post# of 423670
Vascepa (icosapent ethyl) capsules --
Liver injury -- FDA decided that no action is necessary at this time based on available information.

GuidanceComplianceRegulatoryInformation/Surveillance/AdverseDrugEffects/ucm509478.htm

Does anyone know what this is about - when was liver an issue?

I assume this is not a big deal but would like some background on this.

MARZAN already declared on StockTwits that this is purely FUD, without knowing anything about this.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News